Skip to main content

Want a detailed portfolio tracker?

Verastem (VSTM) P/E (2012 - 2026)

Verastem (VSTM) P/E from Jan 27, 2012 to Jul 21, 2026. The TTM Verastem (VSTM) P/E is -2.19. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Verastem (VSTM)

YearP/EChange
2026-2.19-5.38%
2025-2.32+64.97%
2024-1.40-36.17%
2023-2.20+109.45%
2022-1.05-79.51%
2021-5.13-1.57%
2020-5.21+668.30%
2019-0.68-77.59%
2018-3.02+58.55%
2017-1.91+118.73%
2016-0.87-12.53%
2015-1.00-77.71%
2014-4.47-53.40%
2013-9.60-64.99%
2012-27.41N/A

Comparison Verastem (VSTM) P/E with competitors

Verastem (VSTM) P/E is -2.19.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.00-100.20%
ENLVEnlivex Ltd0.07-103.41%
FGENFibroGen Inc0.24-110.95%
CHRSCoherus Biosciences Inc0.85-138.71%
FBIOFortress Biotech Inc0.95-143.30%
ORMPOramed Pharmaceuticals Inc1.50-168.57%
AGENAgenus Inc3.01-237.31%
INVAInnoviva Inc3.15-243.89%
VXRTVaxart Inc3.55-261.95%
CRMDCorMedix Inc3.63-265.54%
CVACCureVac N.V.4.45-302.82%
GLPGGalapagos NV4.86-321.67%
SRPTSarepta Therapeutics Inc4.88-322.73%
ABEOAbeona Therapeutics Inc5.39-345.79%
ABUSArbutus Biopharma Corp5.60-355.29%
ZVRAZevra Therapeutics Inc5.89-368.59%
SPROSpero Therapeutics Inc6.23-384.16%
CGENCompugen Ltd6.31-388.06%
RIGLRigel Pharmaceuticals6.87-413.52%
SLXNSilexion Therapeutics Corp7.30-432.86%
OMEROmeros Corporation9.26-522.41%
AUPHAurinia Pharmaceuticals Inc9.58-537.29%
PLXProtalix BioTherapeutics Inc10.89-596.87%
ACADAcadia Pharmaceuticals Inc11.73-635.08%
TBPHTheravance Biopharma Inc12.26-659.43%
ADMAAdma Biologics Inc12.42-666.55%
HRMYHarmony Biosciences Holdings Inc13.82-730.51%
SABSSAB Biotherapeutics Inc14.14-744.93%
NAGENiagen Bioscience Inc14.82-776.04%
INCYIncyte Corp15.82-821.86%
REGNRegeneron Pharmaceuticals Inc15.86-823.42%
PBYIPuma Biotechnology Inc17.32-889.99%
CPRXCatalyst Pharmaceuticals Inc17.44-895.63%
EXELExelixis Inc17.54-900.13%
TGTXTG Therapeutics Inc18.97-965.28%
MDXGMimedx Group Inc20.55-1037.66%
XOMAXOMA Royalty Corp22.87-1143.63%
ARGXArgen X SE24.30-1208.57%
CTMXCytomX Therapeutics Inc24.82-1232.43%
XOMAOXOMA Royalty Corp25.34-1256.32%
HALOHalozyme Therapeutics Inc25.62-1269.05%
XOMAPXOMA Royalty Corp25.67-1271.17%
VRTXVertex Pharmaceuticals Inc27.99-1377.22%
RPRXRoyalty Pharma plc - Class A28.69-1408.83%
SLNOSoleno Therapeutics Inc29.02-1423.79%
ASNDAscendis Pharma A/S30.09-1472.62%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1829.69%
APLSApellis Pharmaceuticals Inc39.02-1880.29%
BMRNBiomarin Pharmaceutical Inc42.21-2025.86%
KRYSKrystal Biotech Inc45.34-2168.74%
ONCBeiGene Ltd69.54-3272.70%
PHARPharming Group N.V.75.03-3522.95%
TECHBio-Techne Corp101.96-4751.73%
VCELVericel Corp109.92-5115.03%
ALNYAlnylam Pharmaceuticals Inc117.96-5482.01%
GMABGenmab140.29-6500.59%
TLXTelix Pharmaceuticals Ltd162.15-7498.02%
CORTCorcept Therapeutics Inc212.86-9811.36%